Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237315 · ClinicalTrials.gov registry record
Longitudinal Study of Urea Cycle Disorders
A clinical trial of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn, sponsored by Andrea Gropman.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 15
- Study locations
NCT00237315: Recruiting study of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn, sponsored by Andrea Gropman.
NCT00237315 is a study of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn that is actively recruiting participants, run by Andrea Gropman. The registered enrollment target is 1,500 participants, above the 22-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (6718% higher). The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00237315, a study of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn, is actively recruiting participants, sponsored by Andrea Gropman.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
Urea cycle disorders (UCD) are a group of rare inherited metabolism disorders. Infants and children with UCD commonly experience episodes of vomiting, lethargy, and coma. The purpose of this study is to perform a long-term analysis of a large group of individuals with various UCDs. The study will focus on the natural history, disease progression, treatment, and outcome of individuals with UCD.
Conditions Studied
Study Locations (15)
California
- University of California, Los Angeles - Los Angeles
- Stanford University Medical Center - Stanford
Other
- University of Heidelberg - Heidelberg
- University Children's Hospital - Zurich
Colorado
- Children's Hospital Colorado - Aurora
District of Columbia
- Children's National Medical Center - Washington D.C.
Massachusetts
- Children's Hospital Boston (UCDC New England Center) - Boston
Minnesota
- University of Minnesota - Minneapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Ohio
- Case Western Medical College - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2006-02 |
| Est. Completion | 2026-07 |
What NCT00237315 shows while recruiting
NCT00237315 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 22-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (6718% higher).
The record links to 3 conditions, with Urea Cycle Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT00237315 lists 15 locations in 13 states (California, Other, Colorado).
Frequently Asked Questions
What is clinical trial NCT00237315 about?
NCT00237315 is a clinical study titled "Longitudinal Study of Urea Cycle Disorders". Urea cycle disorders (UCD) are a group of rare inherited metabolism disorders. Infants and children with UCD commonly experience episodes of vomiting, lethargy, and coma. The purpose of this study is to perform a long-term analysis of a large group of individuals with various UCDs. The study will fo...
What is the current status of trial NCT00237315?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2006-02. Estimated completion is 2026-07.
What conditions does trial NCT00237315 study?
This clinical trial studies the following conditions: Urea Cycle Disorders, Brain Diseases, Metabolic, Inborn, Amino Acid Metabolism, Inborn Errors.
Who is sponsoring clinical trial NCT00237315?
This trial is sponsored by Andrea Gropman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237315 being conducted?
This trial has 15 study locations across California, Colorado, District of Columbia, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urea Cycle Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
RECRUITING
-
Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
COMPLETED · Phase 2
-
Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants
COMPLETED · Phase 2
-
Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia